--- title: Buy Pulmicort (Budesonide) Inhaler Online description: Pulmicort (Budesonide) Inhaler is a trusted treatment for long-term asthma management. Order from our secure pharmacy for verified quality and delivery. type: product language: en url: https://medsforsale.net/buy-pulmicort-online-en availability: in_stock price_min: 65.54 price_max: 381.89 currency: USD offers: - name: 100mcg x 1 inhaler price: 65.54 - name: 100mcg x 3 inhalers price: 157.69 - name: 100mcg x 6 inhalers price: 302.09 - name: 200mcg x 1 inhaler price: 84.54 - name: 200mcg x 3 inhalers price: 219.44 - name: 200mcg x 6 inhalers price: 381.89 --- # Buy Pulmicort (Budesonide) Inhaler Online Pulmicort, which utilizes the corticosteroid Budesonide, is a cornerstone medication for the long-term management of asthma. Developed by AstraZeneca, it works by reducing inflammation in the airways to prevent or minimize asthma attacks in both adults and children. It is designed for daily preventative use rather than immediate rescue. Our online pharmacy offers a convenient way to access Pulmicort in both 100mcg and 200mcg inhaler options, ensuring you receive a high-quality product for your respiratory health and consistent breathing support. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **100mcg** | 1 inhaler | **$65.54** | $65.54 | In Stock | | **100mcg** | 3 inhalers | **$157.69** | $52.56 | In Stock | | **100mcg** | 6 inhalers | **$302.09** | $50.35 | In Stock | | **200mcg** | 1 inhaler | **$84.54** | $84.54 | In Stock | | **200mcg** | 3 inhalers | **$219.44** | $73.15 | In Stock | | **200mcg** | 6 inhalers | **$381.89** | $63.65 | In Stock | [Buy Now](https://medsforsale.net/buy-pulmicort-online-en) ## Introduction Pulmicort is an inhaled corticosteroid (ICS) indicated for the long-term maintenance treatment of asthma in adults and adolescents aged 12 years and older. The medication contains the active compound budesonide, a synthetic glucocorticoid with potent anti-inflammatory activity in the airways. Pulmicort is supplied as a metered-dose inhaler (MDI) delivering either 100 µg or 200 µg of budesonide per actuation. It belongs to the class of inhaled glucocorticoids, which are a cornerstone of controller therapy for persistent asthma. In addition to its approved asthma indication, budesonide inhalation is sometimes employed off-label for conditions such as chronic obstructive pulmonary disease (COPD) and eosinophilic bronchitis, where clinical evidence suggests benefit, although regulatory approval for these uses is lacking. ## What is Pulmicort? Pulmicort is a brand-name inhaler that delivers the corticosteroid budesonide directly to the bronchial tree. The product was developed by AstraZeneca and first received regulatory clearance in the mid-1990s. Budesonide is also available in other formulations, for example as a nasal spray (Rhinocort) and an oral controlled-release tablet (Enterocort). The inhaled form is marketed under brand names such as Pulmicort, Rhinocort, and Enterocort, each tailored to a distinct route of administration. Pulmicort is supplied in metered-dose inhalers containing propellant-based solution. Each inhaler provides a fixed dose of either 100 µg or 200 µg of budesonide per puff, allowing clinicians to individualize therapy according to disease severity and patient response. ## How Pulmicort Works Budesonide exerts its therapeutic effect by binding to glucocorticoid receptors in the cytoplasm of airway epithelial and inflammatory cells. The drug-receptor complex translocates to the nucleus, where it regulates gene transcription. Key outcomes include: - **Suppression of pro-inflammatory cytokines** (e.g., interleukin-4, interleukin-5, tumor necrosis factor-α). - **Inhibition of eosinophil migration and activation**, reducing airway eosinophilia. - **Up-regulation of β₂-adrenergic receptor expression**, indirectly enhancing bronchodilator responsiveness. These molecular actions translate into reduced airway edema, decreased mucus hypersecretion, and improved airway caliber. Onset of anti-inflammatory action begins within hours, with maximal benefit typically observed after several weeks of consistent use. Budesonide has a high first-pass hepatic metabolism, resulting in low systemic exposure when inhaled correctly. ## Conditions Treated with Pulmicort - **Persistent Asthma (Maintenance Therapy).** Budesonide inhalation controls chronic airway inflammation, decreases the frequency of daytime symptoms, nocturnal awakenings, and the need for rescue inhalers. It is recommended for Step 2-4 of the Global Initiative for Asthma (GINA) treatment algorithm. - **Exercise-Induced Bronchoconstriction (EIB) as Adjunct Therapy.** Regular use of budesonide can reduce airway hyper-responsiveness that underlies EIB, allowing patients to achieve better exercise tolerance. Pulmicort is not approved for acute asthma attacks; short-acting bronchodilators remain the rescue medication of choice. ## Off-Label and Investigational Uses of Pulmicort - **Chronic Obstructive Pulmonary Disease (COPD).** Clinical trials have demonstrated modest improvements in lung function and exacerbation rates when inhaled budesonide is added to bronchodilator regimens. Regulatory agencies have not granted formal approval for COPD, so use must be guided by a specialist. - **Eosinophilic Bronchitis.** Budesonide inhalation can suppress eosinophilic airway inflammation in patients with chronic cough and normal spirometry, a condition that shares pathogenic mechanisms with asthma. - **Allergic Rhinitis (Adjunct Nasal Spray).** While budesonide nasal sprays are approved for allergic rhinitis, some clinicians prescribe the inhaled form when patients experience both nasal and lower-airway symptoms, though evidence is limited. All off-label applications should only be undertaken under direct supervision of a qualified healthcare provider, as safety and efficacy have not been formally established by the FDA or EMA for these indications. ## Is Pulmicort the Right Medication for You? Pulmicort is appropriate for adults with persistent asthma who require daily anti-inflammatory therapy. Ideal candidates are individuals who: - Experience symptoms more than twice a week but less than daily. - Have nighttime awakenings due to asthma at least once a week. - Require a controller medication to reduce rescue inhaler use. Patients with a history of hypersensitivity to budesonide, the propellant, or any excipient in the inhaler should avoid Pulmicort. Those with uncontrolled active infections (e.g., tuberculosis, fungal infection) or recent upper respiratory tract infections may need alternative therapy. Pregnant or breastfeeding women should discuss risk-benefit considerations with their provider, as systemic exposure is low but not negligible. ## Risks, Side Effects, and Interactions ### Common - Hoarseness or throat irritation - Oral candidiasis (thrush) - reduce risk by rinsing mouth after inhalation - Cough immediately after inhalation ### Rare - Dysphonia persisting beyond 4 weeks of therapy - Oropharyngeal bleeding - Reduced bone mineral density with high-dose long-term use ### Serious - Adrenal suppression leading to fatigue, hypotension, or electrolyte imbalance - Severe hypersensitivity reactions (anaphylaxis, angio-edema) - Pneumonia in patients with chronic lung disease ### Drug-Drug Interactions - **CYP3A4 inhibitors** (e.g., ketoconazole, ritonavir) may increase systemic budesonide levels, raising the risk of systemic corticosteroid effects. - **Strong CYP3A4 inducers** (e.g., rifampicin, carbamazepine) could lower budesonide exposure, potentially decreasing efficacy. - Concurrent use of other inhaled or systemic corticosteroids can augment systemic adverse effects, especially adrenal suppression. ### Drug-Food / Lifestyle Interactions - No significant food interactions; however, alcohol excess may exacerbate systemic corticosteroid side effects such as gastric irritation. - Operating heavy machinery is safe for most patients, but caution is advised if dizziness or severe fatigue develops. ## Use: Dosing, Missed Dose, Overdose **Standard dosing** for adults with moderate asthma typically starts at 200 µg twice daily (total 400 µg). For mild disease, 100 µg twice daily may be sufficient. The dose may be titrated upward to a maximum of 400 µg twice daily based on clinical response and tolerance. **Missed dose:** If a dose is forgotten, inhale the missed puff as soon as the patient remembers, provided at least 30 minutes have elapsed since the previous inhalation. If the next scheduled dose is near, skip the missed dose to avoid double dosing and continue with the regular regimen. **Overdose:** In the unlikely event of excessive inhalations (e.g., > 1 mg in a 24-hour period), monitor for signs of systemic corticosteroid excess such as profound fatigue, nausea, vomiting, or facial swelling. Seek medical evaluation promptly. **Practical precautions:** - Inhaler should be stored at room temperature, protected from moisture and heat. - Do not refrigerate; extreme temperatures may alter propellant performance. - Use a spacer device if hand-breath coordination is difficult; this improves lung deposition and reduces oropharyngeal deposition. ## FAQ - **Can I travel internationally with my Pulmicort inhaler?** Yes. The inhaler is allowed in both carry-on and checked luggage in most countries. Keep it in its original packaging and carry a copy of the prescription or a letter from a healthcare provider if required by customs. - **Does Pulmicort contain any lactose or gluten?** The inhaler formulation does not contain lactose or gluten. Inactive ingredients are primarily propellant (hydrofluoroalkane) and ethanol. - **How long does it take for Pulmicort to reach its full therapeutic effect?** Most patients notice improvement in symptoms within 2 weeks, but optimal control may require 4-8 weeks of consistent use. - **Is a spacer mandatory for using the Pulmicert inhaler?** A spacer is not mandatory, but it is recommended for certain populations (e.g., children, elderly, or those with coordination difficulties) because it improves lung deposition and reduces oral side effects. - **What should I do if I develop a hoarse voice after using Pulmicort?** Rinse the mouth and gargle with water after each inhalation. If hoarseness persists for more than two weeks, contact a healthcare professional for evaluation. - **Are there any differences between the 100 µg and 200 µg inhaler devices?** Both devices use the same propellant system and inhalation technique; the only difference is the amount of budesonide delivered per actuation. Selecting the appropriate strength depends on disease severity and physician guidance. - **Can Pulmicort be used during pregnancy?** Budesonide has low systemic absorption when inhaled, and limited human data suggest it is relatively safe in pregnancy. Nonetheless, patients should discuss potential risks and benefits with their obstetrician. - **Will using Pulmicort affect a drug test?** Inhaled budesonide is not screened for in standard occupational or sports drug tests, as it is a corticosteroid, not an anabolic agent. - **What is the shelf life of an unopened Pulmicort inhaler?** Unopened inhalers typically retain potency for 24 months from the date of manufacture, provided they are stored at ≤ 30 °C and protected from moisture. - **Is there any special disposal method for used Pulmicort inhalers?** Used metered-dose inhalers should be returned to a pharmacy or a certified hazardous-waste collection point because the propellant is classified as a greenhouse gas. ## Glossary **Glucocorticoid receptor** : A cytoplasmic protein that binds corticosteroids, translocates to the nucleus, and regulates inflammatory gene expression. **First-pass metabolism** : The rapid hepatic metabolism of a drug after oral absorption, which reduces systemic exposure; inhaled budesonide bypasses this pathway, limiting systemic effects. **Spacer device** : An add-on chamber placed between the inhaler and the mouth that holds the aerosol cloud, allowing inhalation of finer particles and reducing oropharyngeal deposition. **Adrenal suppression** : A reduction in endogenous cortisol production caused by prolonged exposure to exogenous steroids, potentially leading to fatigue, hypotension, and electrolyte disturbances. ## Buying Pulmicort from [our online pharmacy](https://medsforsale.net/buy-pulmicort-online-en) Pulmicort can be obtained safely through **[our online pharmacy](https://medsforsale.net/buy-pulmicort-online-en)**. By sourcing the medication from licensed, overseas suppliers, we are able to offer the inhaler at a price that closely reflects the manufacturer’s cost, eliminating the markup commonly seen in retail chains. Every batch is verified for authenticity and potency before shipment, ensuring that patients receive a product that meets international quality standards. Delivery is discreet and reliable: standard airmail typically arrives within three weeks, while an express option is available for delivery in about seven days. All packages are packaged without labeling that could disclose the contents, safeguarding patient privacy. Our pharmacy broker service operates under strict regulatory compliance, partnering only with certified pharmacies that adhere to Good Manufacturing Practices (GMP). This model enables patients with limited access through traditional channels to obtain the treatment they need without compromising on safety, affordability, or confidentiality. ## Disclaimer The information presented about **Pulmicort** is intended for general educational purposes and does not replace professional medical advice. Treatment decisions, including any off-label applications, should be made under the guidance of a qualified healthcare practitioner. Readers are assumed to be responsible adults capable of evaluating health information independently. **[our online pharmacy](https://medsforsale.net/buy-pulmicort-online-en)** provides access to **Pulmicort** for individuals who may encounter restricted availability through conventional pharmacies, insurance formularies, or who seek cost-effective generic alternatives. Always discuss any medication changes with a qualified clinician before initiating, modifying, or discontinuing therapy.